Navigation Links
CEL-SCI Corporation Reports Second Quarter 2008 Financial Results
Date:5/16/2008

ial. Multikine appears to be the first non-toxic cancer drug.

Multikine, a patented defined mixture of naturally derived cytokines, is the first immunotherapeutic agent in a new class of drugs called "Immune SIMULATORS". Immune SIMULATORS simulate the way our natural immune system acts in defending us against cancer. As opposed to other immunotherapies which are designed to target a single or limited number of specific antigens or molecules, Immune SIMULATORS are multi-targeted; they simultaneously cause a direct and targeted killing of the specific tumor cells and they activate the immune system to produce a stronger anti-tumor attack on multiple fronts.

Multikine is also the first immunotherapeutic agent being developed as a first-line standard of care treatment for cancer. It is administered prior to any other cancer therapy because that is the period when the anti-tumor immune response can still be fully activated. Once the patient has advanced disease, or had surgery or has received radiation and/or chemotherapy, the immune system is severely weakened and is less able to mount an effective anti-tumor immune response. Other immunotherapies are administered after the patient has received chemotherapy and/or radiation therapy, which can limit their effectiveness.

The Company's loss from operations for the quarter ended March 31, 2008 was $2,085,098 versus a loss from operations of $2,012,605 during the same quarter in 2007. The net loss per common share for the quarter ended March 31, 2008 was $0.03 which was unchanged from the same quarter in 2007. The Company's loss from operations for the six months ended March 31, 2008 was $4,952,536 versus a net loss from operations of $3,592,516 during the same six months in 2007. The Company's net loss per common share for the six months ended March 31, 2008 was $0.05 which was unchanged from the same six month period in 2007.

During the three month period ended March 31, 2008, research and devel
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. CEL-SCI CORPORATION Announces Results of 2008 Annual Meeting of Shareholders and Provides Update on Ground-breaking Activities Regarding Construction of Manufacturing Facility for Pivotal Phase III Cancer Trial
2. CEL-SCI Corporation Releases Letter to Shareholders
3. CEL-SCI Corporation Announces Adoption of Shareholder Rights Plan
4. Comprehensive Review of Cancer Immnunotherapies Published By CEL-SCI
5. RediStat Corporation Partners With ALERT FM for Disaster-Proof Emergency Communications
6. Select Medical Corporation Announces Results for First Quarter Ended March 31, 2008
7. Diagnostic Health Corporation Names Robert E. Gontarek as COO
8. AGA Medical Corporation Receives CE Mark Approval for the AMPLATZER(R) Vascular Plug III
9. Insulet Corporation to Present at the Seventh Annual JMP Securities Research Conference on May 20, 2008
10. Somanetics Corporation to Present at Citigroup 2008 Healthcare Conference
11. CRH Medical Corporation opens Center in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... U.S. Pharmacopeial Convention is pleased to announce that Gigi ... North Carolina State’s College of Veterinary Medicine has been ... Distinguished Volunteer Service—the organization’s highest award. , Since ... experts to direct its work to improve the health ...
(Date:1/22/2015)... 2015 Gabe’s Chemo Duck Program is pleased to ... app ever created for kids with cancer. The Chemo Duck App, ... is filled with enjoyable games to help children of all ages ... app helps to keep kids entertained, educated and at ease while ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) ... to “Live Fearless.” , The “Faces of Fearless” ... about how they or someone they know has faced a ... the moment. By telling these types of stories through livefearlessmn.com, ...
(Date:1/22/2015)... January 22, 2015 Thousand of GranuFlo ... Care recalled its GranuFlo and NaturaLyte dialysis concentrates continue ... in U.S. District Court, District of Massachusetts, Bernstein Liebhard ... the Court has remanded a case filed by the ...
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 ... College of Sports Medicine flagship journal Medicine & ... with L-Citrulline before exercise may help reduce gastrointestinal ... exercise. 1 , Participants in the double-blind, ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
... is expected to be conducted in China for the first time ... had suffered extensive burn injuries // two years ago. The burn ... in an act of revenge against the girl’s parents. ... were to endanger her life. The General Hospital of Nanjing Military ...
... the University of Michigan in his survey in 50,000 teen ... these students but alarmingly found an increase in drug abuse ... 50% of students in the 12th grade are abusing drugs. ... increased stress these students are exposed or due to their ...
... thiamine (vitamin B1) states that a deficiency in vitamin ... surgery to treat obesity//. This is based on a ... American Academy of Neurology. ,The study ... lead to Wernicke’s encephalopathy, a severe neurological condition. ...
... in the rooms, restaurants, bars and public areas of its ... January 2006//., ,Guests will only be allowed to smoke ... said research among its customers had revealed that 92 percent ... to walk into a smoky guest room, not even smokers," ...
... Picower Institute for Learning and Memory shows that neurons tend to ... of adult brain // lacks the capacity to grow as a ... research on the various techniques that could induce growth in the ... genetic or the sensory or by other ways that could lead ...
... called upon the procedures at the Wellington Hospital to be ... Laurent // , of pneumonia. The junior doctors of the ... ,The patient had been suffering from symptoms similar to flu ... hospital about a week before her death when she was ...
Cached Medicine News:Health News:More The Usage More The Growth In The Adult Brain. 2
(Date:1/23/2015)...  Today the U.S. Food and Drug Administration (FDA) announced ... serogroup B meningococcal disease in individuals ages ... received FDA approval in October, represent a significant step ... "I have heard over and over from parents ...
(Date:1/23/2015)... Jan. 23, 2015  A new analysis of Centers for ... enrollment data shows that 81 percent of seniors chose ... extra discounts at certain pharmacies. The findings were released ... plans are now the foundation of Medicare Part D," ...
(Date:1/23/2015)... , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( ... of directors of Advaxis, Inc. ("Advaxis" or the "Company") ... has breached its fiduciary duties to shareholders. ... an investing website reporting that Advaxis had misrepresented the ...
Breaking Medicine Technology:The National Meningitis Association (NMA) Applauds FDA Approval of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 2New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2
... ,The LMA ProSeal™ is the most ... enables seal pressures of 30cm H2O and ... separates the alimentary and respiratory tracts. These ... enable longer periods of ventilation with minimal ...
... superior, disposable supraglottic airway tool that utilizes ... design to provide the best non-intubating airway ... a safe, reliable, cost effective and efficient ... laryngoscopy is not feasible or attainable. With ...
... material, Available in even sizes 20-36F. Single ... maximizing patient comfort. The Latex-Free Robertazzi is ... while offering the best solution for latex ... to offer a quality latex-free product as ...
Soft red rubber. Adjustable flange. Pediatric sizes available....
Medicine Products: